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Abstract
We compared the in vitro fidelity of wild-type human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) and the prototype
foamy virus (PFV) RT. Both enzymes had similar error rates for single nucleotide substitutions; however, PFV RT did not appear to make errors at
specific hotspots, like HIV-1 RT. In addition, PFV RT made more deletions and insertions than HIV-1 RT. Although the majority of the missense
errors made by HIV-1 RT and PFV RT are different, relatively few of the mutations caused by either enzyme can be explained by a misalignment/
slippage mechanism. We suggest that the higher polymerase activity of PFV RT could contribute to the ability of the enzyme to jump to the same
or a different template.
Published by Elsevier Inc.Keywords: Fidelity; Reverse transcriptase; Spumavirus; HIV-1; LentivirusIntroduction
Foamy viruses (FVs) are retroviruses (subfamily Spumare-
trovirinae) but are in some ways distinct from typical
retroviruses. The order of the gag, pol, and env genes in the
FV genome is the same as in orthoretroviruses and, like
orthoretroviruses, FVs convert their single-stranded RNA
genomes into double-stranded DNA using a virally encoded
reverse transcriptase (RT). This double-stranded DNA is then
inserted into the host genome by a virally encoded integrase
(IN), creating a provirus flanked by long terminal repeats
(LTRs). However, FVs have distinct features that set them apart
from orthoretroviruses (for reviews, see Delelis et al., 2004;
Falcone et al., 2003; Linial and Weiss, 2001). The prototype
primate foamy virus (PFV), originally designated as human
foamy virus (HFV), then as simian foamy virus-chimpanzee
(human isolate) [SFVcpz(hu)], is a chimpanzee FV isolated
from a human-derived cell culture (Lochelt et al., 1991). In PFV
infections, viral DNA is synthesized in the producer cell rather⁎ Corresponding author. Fax: +1 301 846 6966.
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DNA genome. Some DNA synthesis can also occur in the
newly infected cell (Delelis et al., 2004). PFV RT is not
synthesized as part of a Gag-Pol polyprotein; instead, the Pol
polyprotein is expressed from a separate spliced message. When
PFV virions mature, there is minimal proteolytic cleavage of the
Gag and Pol polyproteins; IN is processed from the Pol
polyprotein, but protease (PR) appears to remain attached to RT.
In orthoretroviruses, association of the Gag-Pol polyprotein
with the Gag polyprotein allows the Gag-Pol polyprotein to be
packaged into the virion. Because PFV does not synthesize a
Gag-Pol polyprotein, the Pol polyprotein must be packaged into
the PFV virion by other means. The Pol polyprotein appears to
be packaged into PFV virions because it binds to certain regions
of the viral nucleic acid (Peters et al., 2005). The different mode
of FV Pol polyprotein packaging means that there are fewer RT
molecules in a PFV virion than in a virion of an orthoretrovirus.
As might be expected from the relatively small number of RT
molecules in a virion, PFV RT has a higher level of polymerase
activity than HIV-1 RT (Boyer et al., 2004a,b; Rinke et al.,
2002). Given this higher level of polymerase activity, we asked
whether PFV RT had a similar, higher, or lower fidelity than
HIV-1 RT. One reason to consider the possibility that PFV RT
Table 1
Summary of mutation frequencies and error rates
RT Total no. of
mutations
Total no. of
colonies
Mutation
frequency
Error rate
HIV-1 176 13,186 0.013 7.5×10−5
PFV 208 7033 0.03 1.7×10−4
The total number of mutations detected by DNA sequencing was divided by the
number of colonies screened by using the blue/white colorimetric assay. This
gives the mutation frequency (mutations/colony). The total length of the target
sequence is defined as being 174 nt (from the starting GGA codon to the end of
the first termination codon). Dividing the mutation frequency by the length of
the LacZα coding region gives the error rate (mutations/nt).
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infects African green monkeys (SFVagm), there is relatively
little genetic drift in the viral sequences either in the infected
primates or in a human accidentally infected through contact
with infected animals (Schweizer et al., 1997, 1999). In
contrast, HIV-1 shows considerable genetic variation in infected
humans. This genetic variation is caused by a combination of
the errors in the genome generated by either the RT or by the
host DNA-dependent RNA polymerase (while in theory errors
could be generated by the DNA-dependent DNA polymerases
copying the provirus during host cell DNA replication, the
fidelity of these enzymes is sufficiently high that they will not
make a significant contribution to the overall genetic variation
of exogenously propagated retroviruses in an infected indivi-
dual). The fidelity of the host DNA-dependent RNA polymer-
ase is not known, so the contribution it makes to the overall
fidelity of viral replication is undefined. The number of errors
that occur depends to a large degree on the replication rate of the
virus. The relatively rapid genetic variation in HIV-1 in patients
(leading to the generation of quasispecies) is primarily caused
by the rapid replication of the virus (Coffin, 1995; Brown, 1997;
Ganeshan et al., 1997; Telenitsky and Goff, 1997; Van Laethem
et al., 2005; and references therein).
As mentioned above, the FVs have much lower rates of
genetic variation than does HIV-1. It is likely that the primary
cause of this relative lack of variation is that, in infected
primates or humans, the virus replication is much lower than
HIV-1 (Murray et al., 2006). However, it is also possible that the
FV RT has a lower overall error rate. Given the complexities of
trying to distinguish the contributions of both the host DNA-
dependent RNA polymerase and RT, we have approached the
problem by measuring the fidelity of PFV RT in vitro and
comparing it to the fidelity of HIV-1 RT. We measured the
fidelity of the two RTs by copying a DNA segment encoding the
α-complementing peptide of Escherichia coli β-galactosidase.
This DNA segment was incorporated into a plasmid and
introduced into E. coli. Mutations in the α-complementing
segment were scored by a colorimetric assay and the nature of
the mutation was determined by DNA sequencing.
In this system, we found that HIV-1 RT and PFV RT had
similar error rates for single nucleotide substitutions. The
locations of the nucleotide substitutions were different for the
two RTs. DNAs synthesized by PFV RT had a significantly
higher level of frameshifts, deletions, and insertions compared
to DNAs synthesized by HIV-1 RT. We previously reported that
the polymerase activity of PFV RT is significantly higher than
that of HIV-1 RT (Boyer et al., 2004a,b; Rinke et al., 2002). We
propose that this higher polymerase activity of PFV RT leads to
a higher level of template jumping by the enzyme, either to the
same template or to a different template. Our data suggests that
the genetic stability of the FV genomes is not due to the
presence of a high fidelity RT.
Results and discussion
We modified the previously described fidelity assay (Boyer
and Hughes, 2000) by the addition of the QIAprep M13isolation protocol, which removes impurities from the DNA that
could alter the fidelity of the RT during polymerization. To test
the modified assay system, wild-type HIV-1 RT was used to
polymerize using anti-sense lacZα U-DNA as template, and
these results were compared to our previous results (Boyer and
Hughes, 2000). A total of 13,186 colonies were screened; 176
mutations were detected by a combination of a blue/white color
screen for β-galactosidase activity in E. coli strain expressing
the ω-complementary segment of β-galactosidase, and sequen-
cing. This gives a mutation frequency (mutations/colony) of
0.013 (Table 1), which is similar to the results obtained by us
and by others (Bebenek et al., 1995; Boyer and Hughes, 2000;
Drosopoulos and Prasad, 1998; Jonckheere et al., 2000; Kim et
al., 1999; Lewis et al., 1999; Rezende et al., 1998a,b, 2001;
Shah et al., 2000; Stuke et al., 1997; for reviews see Rezende
and Prasad, 2004; Svarovskaia et al., 2003; Telenitsky and Goff,
1997). As described in Materials and methods, the target
sequence was 174 nucleotides (nt) in length, which yields an
overall error rate (mutation frequency/nt) of 7.5×10−5 (Table
1). This is slightly lower than the error rate of 1.6×10−4 we
obtained previously (Boyer and Hughes, 2000). Because only
mutations that affect the function of the LacZα peptide are
scored in the blue/white assay and subsequently sequenced,
these frequencies underestimate the actual error rate of the
enzyme. Of the 176 mutations detected, 106 were transitions
(60%), 44 were transversions (25%), while the remaining 26
mutations were frameshifts, deletions, and repeated sequences
(15%) (Tables 2 and 3). In our previous experiments, we found
more transversions and fewer transitions (Boyer and Hughes,
2000), suggesting that the QIAprep system removed impurities
that affected the errors made by HIV-1 RT. The majority of the
transitions were G→A mutations (80/106; Table 2), which
agrees with our previous data (Boyer and Hughes, 2000). There
have been reports that G→A mutations are frequently detected
when HIV-1 is grown in vivo (Janini et al., 2001; Lecossier et
al., 2003; Stuke et al., 1997; Telenitsky and Goff, 1997; Turner
et al., 2005; Vartanian et al., 2002 and references therein). While
some of the G→A mutations that arise during viral replication
may be due to the activity of members of the host APOBEC
gene family (for review, see Huthoff and Malim, 2005), our
results indicate that HIV-1 RT may generate some of the G→A
mutations found in the HIV-1 genome. Other transitions
occurred at a lower frequency (Table 2). While transversions
occurred less frequently than transitions, almost all of the
Table 3
Summary of the frameshift, deletion, and repeat mutation frequency and error
rate
HIV-1 PFV
Frameshift 18 25
Error rate 8.0×10−6 2.1×10−5
Short deletions/additions 4 21
Error rate 1.7×10−6 1.7×10−5
Deletions 3 76
Error rate 1.3×10−6 6.2×10−5
Repeats 1 16
Error rate 4.0×10−7 1.3×10−5
These were calculated as described in the legend to Table 1, except that the
number of frameshift, deletion, and repeat mutations were used in the
calculations.
Table 2
Summary of the single nucleotide substitutions generated by the two RTs
HIV-1 PFV
Transversions
C→A 21 15
T→A 17 6
G→C 4 1
T→G 1 1
A→C 1 4
C→G 0 6
G→T 0 2
44 35
Transitions
C→T 13 4
G→A 80 25
A→G 11 5
T→C 2 1
106 35
Overall error rate 6.3×10−5 5.8×10−5
The number of transitions and transversions, as well as the type of base
substitution, is shown. The error rate for transitions and transversions combined
were calculated in a manner similar to that described for Table 1, except the
number of single nucleotide substitutions was used.
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also agrees with our previous data (Boyer and Hughes, 2000). In
combination with the G→A mutations described above, this
suggests that under the conditions we use, purified HIV-1 RT
tends to misincorporate dATP more often than other nucleo-
tides. Other groups have detected fewer adenine substitutions,
suggesting that reaction conditions and/or the nature of the
purified RT can play a significant role in the observed fidelity of
HIV-1 RT (Bebenek et al., 1995; Drosopoulos and Prasad,
1998; Jonckheere et al., 2000; Kim et al., 1999; Lewis et al.,
1999; Rezende et al., 1998a,b, 2001; Shah et al., 2000; Stuke et
al., 1997). Frameshift mutations, deletions, and one sequence
repeat error comprised the remainder of the mutations (Table 3).
The locations of the base substitutions generated by wild-
type HIV-1 RT are shown in Fig. 1. There is evidence for
mutational hotspots in the sequence, and, in most cases, there
was a preferred nucleotide substitution for each hotspot. For
example, there is a hotspot in the GGA glycine codon at the
beginning of the lacZα coding region. The only mutation
detected was a G→A transition at the first G. Only a few
locations within the lacZα coding region had more than one type
of nucleotide substitution when HIV-1 RT was used as the
polymerase; these positions are highlighted (Fig. 1). It has been
suggested that homopolymeric regions play a role in the
generation of missense mutations (Kunkel and Alexander, 1986;
Kunkel and Soni, 1988); this model, termed “Dislocation
Mutagenesis”, involves the slippage or misalignment in a
homopolymeric region during polymerization, followed by the
incorporation of the next nucleotide that can pair with the base
that immediately follows the homopolymeric region. After this
misincorporation, the DNA strands realign, generating a mispair
at the end of the primer strand. Subsequent polymerization from
the mispaired end completes the base substitution process
(Kunkel and Soni, 1988). In our assay, there is only one position
(position 112 [G→A]) that clearly matches the sequence
requirements for dislocation mutagenesis that could beconsidered a mutational hotspot (with 7 substitutions) (Fig. 1).
Three additional positions (positions 130 [C→A], 142 [C→T],
177 [T→A], and 184 [G→A], match the sequence requirements
for the dislocation mutagenesis model (assuming 2–3 residues
is a homopolymeric region); however, these positions are not
mutational hotspots (Fig. 1). Most of the mutational hotspots in
our assay cannot be explained by dislocation mutagenesis,
suggesting that direct misinsertion of the incorrect base is the
primary mutagenic process and other mechanisms (such as the
overall sequence surrounding the hotspot) plays a dominant role
in determining mutational hotspots.
Some of the frameshift mutations (defined as a gain or loss of
one nucleotide) generated by HIV-1 RT are near short
homopolymeric stretches, and a misalignment/slippage
mechanism could account for some of the frameshifts in these
regions (Fig. 2) (Bebenek et al., 1989, 1993; Kunkel, 1990). If
the slippage occurs in the template strand, creating an
extrahelical base, the primer strand will be 1 nucleotide shorter
than expected. Primer slippage with an extrahelical base would
allow the primer strand to gain one nucleotide. An example of a
loss of a nucleotide due to template slippage is seen near
position 119, where a C residue is lost from a tract of three C
residues (AAC CCT GGC→ AAC CTG GC). An example of a
gain of a nucleotide in a homopolymeric tract (primer slippage)
is seen near position 110, where a G residue is added to a tract of
G residues (TGG GAA AAC → TGG GGA AAA C) (Fig. 2).
However, the simplest form of the misalignment/slippage
mechanism would involve the gain or loss of one or more of
the residues within the homopolymeric tract, depending upon
whether the misalignment involves the primer or template
strand (Bebenek et al., 1989, 1993; Hamburgh et al., 2006;
Kunkel, 1990). For some of the frameshifts detected near a
homopolymeric region, the nucleotide that was inserted did not
match the homopolymeric sequence. For example, near position
85, an A residue was inserted between two C residues (GCC
GTC→GCA CGT C). In addition, there are other frameshifts
generated by wild-type HIV-1 RT that do not occur in
homopolymeric regions. This is similar to our previous
observations (Boyer and Hughes, 2000). Again, this suggests
that mechanisms other than primer/template slippage may be
involved in generating these frameshifts. It has been shown that
sites and/or sequences within the template strand that contribute
256 P.L. Boyer et al. / Virology 367 (2007) 253–264to the termination of processive DNA synthesis could contribute
to frameshift errors (Bebenek et al., 1989, 1993). Sequence
changes could influence locations where processive synthesisterminates and thus affect frameshift fidelity (Abbotts et al.,
1993; Bebenek et al., 1989, 1993). Another possibility is the
base-sharing model. It has been suggested that the polymerase
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the bulge created by the presence of an extrahelical base (either
in the primer or template strand). In base sharing, the extra base
may be kept within the duplex (albeit, with the introduction of a
kink in the phosphate backbone) causing two bases to interact
with a single base on the opposite strand (Hamburgh et al.,
2006). While this model has been proposed for homopolymeric
tracts, it is possible that the base sharing could occur in other
sequences giving rise to the substitutions we have seen in the
experiments described here (Fig. 2).
Mutations that involved the gain or loss of 2 or 3 nt were
classed as small deletions/insertions (Fig. 2). As described
above, it has been proposed that the polymerase active site of
HIV-1 RT is unlikely to accommodate extrahelical bases
created by template or primer slippage (Hamburgh et al., 2006),
and it is unlikely that base sharing could involve three bases on
the same strand. Larger deletions and insertions should be even
less likely to be generated by HIV-1 RT. As shown in Fig. 2,
four mutants were isolated which had lost two nucleotides from
the LacZα sequence. These four mutants are not clustered
together on the sequence, and the mechanism by which they
were generated is not known. It is known that larger deletions
and insertions can occur during the replication of HIV-1.
Insertion or deletion of one or more codon(s) can result in the
appearance of drug-resistant RT variants (e.g., Boyer et al.,
2004a,b; Sarafianos et al., 2004 and references therein) and
deletions/insertions are known to occur in the coding sequence
of envelope (e.g., Ganeshan et al., 1997; Van Laethem et al.,
2005, and references therein). Whether these deletions and
insertions are the result of errors by the HIV-1 RT or the host
RNA pol II is not known.
Larger deletions or insertions were relatively rare when HIV-
1 RTwas the polymerase used in the fidelity assay (Fig. 3). One
large insertion was detected in which the duplicated region
included the entire LacZα coding region to the penultimate
tryptophan codon; however, at this point the primer either
annealed to a different template or was somehow ligated to
another LacZα DNA segment, creating a segment in which
there are two complete LacZα coding regions in the plasmid.
Only one such mutant was recovered; events of this type are
expected to be a rare. HIV-1 RT also generated three deletions.
In one mutant, it appears that a large misalignment/slippage
occurred (Fig. 3). The primer jumped from the sequence (GTT
ACC CAA CTTAAT) to a related sequence, shown underlined,
approximately 78 nucleotides downstream (TCC CAA CAG
TTG). A second deletion spans a similar region and it is likely
that the same type of misalignment/slippage mechanism is
responsible for both of these deletions. The third deletion
mutation resulted in the loss of 5 codons and does not involveFig. 1. The locations of the single nucleotide substitutions generated by both HIV-1 R
peptide generated in our system is a fusion peptide. In our analysis, the N terminus of t
is highlighted in bold. The sequence of the plasmid that is 3′ of the termination codon
target lacZα sequence is underlined (GGA). The numbering system starts from the fir
the first base added by either HIV-1 RT or PFV RT when polymerizing across the te
normal lacZα sequence. The amino acid sequence is shown below the lacZα seque
highlighted.the same region as the other two deletions just discussed (Fig.
3). There is no clear sequence homology that would allow a
conventional misalignment/slippage to occur in this region and
the mechanism that generated this mutant in unknown.
Fidelity of wild-type PFV RT
The purified wild-type RT from PFV was allowed to extend a
primer across the LacZα coding region under conditions
identical to those used for HIV-1 RT. A total of 7033 colonies
were examined by the colorimetric assay for β-galactosidase. A
total of 208 mutations were detected by sequencing, yielding a
mutation frequency of 0.03 mutations/colony and an error rate
of 1.7×10−4 mutations/bp (Table 1). This would suggest that
PFV RT is more error prone than is HIV-1 RT. However, this is
somewhat misleading because many of the PFV RT errors are
frameshifts, deletions and repeats rather than base substitutions
(described below). Of the 208 mutations detected, 35 were
transitions (17%), 35 were transversions (17%), while the
remaining 138 mutations were frameshifts, deletions, and
insertions (66%) (Tables 2 and 3). If the error rate for single
nucleotide substitutions is calculated for both RTs, the error rate
for HIV-1 RT is 6.5×10−5 errors/bp while the error rate for PFV
RT is 5.8×10−5 errors/bp, which is quite similar (Table 2).
There is a report that an HIV-1 RT variant that is more
processive than the wild-type HIV-1 RT had a mutation
frequency that was similar to wild-type HIV-1 RT (Rezende et
al., 2001). PFV RT is significantly more processive than is wild-
type HIV-1 RT, yet the rate of nucleotide substitutions is similar
for these two RTs. It has been suggested that the constraints
within the polymerase active site might have a greater role in
determining the fidelity of the enzyme than the level of
polymerase activity (e.g., Arora et al., 2005; Cramer et al.,
2002; Kim et al., 2005, 2006; Weiss et al., 2000). Our data
supports this model. Unlike HIV-1 RT, where transitions
occurred twice as frequently as transversions, the number of
transitions and transversions was approximately the same for
PFV RT. PFV RT is similar to HIV-1 RT in that many of the base
substitutions were to adenine (Table 2). From a total of 35
transversions isolated, 15 were C→A, while 6 were T→A. Of
the 35 transitions detected, 25 were G→A (Table 2). However,
PFV RT does not have clear mutational hotspots to the extent
that HIV-1 RT does; the mutations caused by PFV RT appear to
be more evenly distributed than those caused by HIV-1 RT (Fig.
1). For example, even though the G→A error rate is high for
both RTs, the tryptophan codon at positions 110 and 170 are
mutated to different extents. HIV-1 RT has a mutational hotspot
at both of these positions (described above), but PFV made only
a few G→A transitions at these positions (Fig. 1).T and PFV RT are shown. As described in the Materials and methods, the lacZα
his peptide was not included as part of the mutational target. This leader sequence
s, and therefore not translated, is also highlighted in bold. The first codon of the
st nucleotide of the unique EcoRI site present in the Litmus-29 (Not). This is also
mplate. The nucleotide substitutions detected for each RT are shown above the
nce. Positions where there is more than one type of nucleotide substitution are
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Fig. 3. Repeats and deletions generated by HIV-1 RT. As described in Fig. 1, Bold indicates the lacZα leader sequence. GAATTC is the EcoRI site where
polymerization by RT begins in the leader sequence. The vertical line (|) indicates the endpoint of the normal sequence, the beginning of a repeated sequence or the
beginning of the sequence after the deletion is shown after this symbol. The locations of the endpoints of the deletion are shown by the numbers underneath the
sequence.
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HIV-1 RT and PFV RT are statistically different. The population
in a particular class of mutations (transversions, transitions, etc.)
was divided by the total number of colonies tested (13,186 for
HIV-1 RT or 7033 for PFV RT) to provide a percentage. These
percentages were compared to each other using a two-sided
Fisher's exact test of two independent proportions. A value of
pb0.05 is considered statistically significant and, by this
measure, the percentage of certain types of mutations generated
by HIV-1 RTand PFV RTare statistically different (Table 4). As
shown in Table 4, the number of transversions generated by
HIV-1 RT and PFV RT are not statistically different, and PFV
RT cannot be considered to generate more transversions than
does HIV-1 RT. However, the number of transitions generated
by HIV-1 RT is statistically different from the number of
mutations generated by PFV RT. HIV-1 RT is more prone to
generating transitions than is PFV RT (Table 4).
The major reason for the lower level of fidelity measured for
PFV RT compared to HIV-1 RT is in the increase in the number
of frameshifts, deletions, and insertions generated by PFV RT
(Table 3). As shown in Table 4, the differences measured
between HIV-1 RT and PFV RT are statistically different. As
shown in Fig. 2, many of the locations of the frameshiftsFig. 2. The locations of the frameshifts and short deletions/additions generated by HIV
Short deletions and additions are the gain or loss of 2 or 3 nucleotides. Deletions are
nucleotide(s). If more than one nucleotide was deleted, the delta symbols are brackete
(highlighted) embedded within the normal flanking nucleotides. Each individual fram
frameshift was found, the total number of the identical frameshift is shown as a mu(defined as a gain or loss of one nucleotide) generated by PFV
RT differ from the locations of frameshifts generated by HIV-1
RT. This difference suggests that the two RTs interact differently
with the template-primer. A misalignment/slippage mechanism
or base sharing in a homopolymeric region (assuming, as
described above, that two bases constitute a homopolymeric
tract) can account for many of the frameshifts generated by PFV
RT. For example, a slippage or base sharing in the template
strand could account for the six mutants that lost a cytidine
residue at position 158, which is in a segment that contains five
contiguous cytosines (Fig. 2). In the same segment, a
misalignment/slippage mechanism or base sharing in the primer
strand can account for the four mutants that gained a cytosine
(Fig. 2).
Short deletions and insertions (gain or loss of 2 or 3
nucleotides) are much more common when PFV RTwas used in
the assay compared to HIV-1 RT (Table 3; Fig. 2). It is not clear
what mechanism gives rise to these small deletions and
insertions. However, because most of these mutations are
deletions (Fig. 2), it is likely that the template strand was not
completely in register relative to the primer strand when the
template was copied by PFV RT. It is possible that the active site
of PFV RT is not as tightly constrained as the polymerase active-1 RT and PFV RT. Frameshifts are defined as the gain or loss of one nucleotide.
indicated by a Greek delta (Δ) above the lacZα sequence indicating the deleted
d [ΔΔ]. Insertion of a nucleotide is indicated by showing the inserted nucleotide
eshift is on a separate line above the lacZα sequence. If more than one identical
ltiplier (2×, etc.).
Table 4
Statistical analysis of the differences in HIV-1 RT and PFV RT fidelity
HIV-1 (%) PFV (%)
Transversions 0.33 0.50 p=0.077
Transitions 0.80 0.50 p=0.013
Frameshifts 0.14 0.36 p=0.002
Short deletions, additions 0.03 0.30 pb0.001
Deletions 0.02 1.08 pb0.001
Repeats 0.01 0.23 pb0.001
Total 1.33 2.97 pb0.001
Analysis of the mutations generated by HIV-1 RT and PFV RT. The percentage
of each type of mutation is derived by dividing the number of mutations of each
type by the total number of colonies screened. A test of independent proportions
was done to see if the number of each type of mutation generated by HIV-1 RT
and PFV RT are statistically different from each other. The statistical tests of
independent proportions were done using two-sided Fisher's Exact Tests using
SAS Proc Freq. A p-valueb0.05 declares that the differences are statistically
significant.
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template strand that would allow 2–3 nucleotides to loop out.
The small deletions are not clustered at particular sequences,
and seem to be evenly distributed in both homopolymeric tracts
and non-homopolymeric tracts. It is unlikely that a simple
misalignment/slippage or base sharing mechanism would
account for a loss of multiple nucleotides, and the mechanism
that generates these small deletions may be related to the
processes that generate larger deletions (discussed below).
PFV RT generated a large number of deletions in this assay
(Supplementary material); out of 208 total mutations, 76 were
large deletions (Table 3). It has been shown that for mutants of
HIV-1 RT, the degree of processivity can affect the level of
frameshift mutations (Bebenek et al., 1995; Kim et al., 1999,
and references therein). Considering the large number of
deletions generated by PFV RT, it is possible that the major
mechanism creating deletions involves misreading of the
template due to the greatly increased processivity and
polymerization of the PFV RT compared to HIV-1 RT
(Boyer et al., 2004a,b; Rinke et al., 2002). We previously
showed that sequences that terminate processive DNA
synthesis by HIV-1 RT do not interfere with processive
DNA synthesis by PFV RT (Boyer et al., 2004a,b). Deletions
could be caused by a template switching mechanism; however,
this type of mechanism would be expected to generate an equal
number of insertions and deletions. In fact, we found many
more deletions than insertions, suggesting that there might be a
preference for jumping to the same template rather than to a
different template.
For some of the mutations, there are sequence homologies
that may be involved in generating the deletion (Supplementary
material). However, for many of the deletion mutations, there
are no obvious sequence homologies that would explain how
PFV RT skips over a segment of the template strand without
copying it (Supplementary material). We considered the
possibility that PFV RT might polymerize across the base of
stem-loop structures in the template DNA, thus causing the
large deletions. The program mfold was used to generate
putative secondary structures in the template strand. However,there is no obvious correlation between the three most stable
stem-loop structures predicted by mfold and the locations of the
deletion start points (data not shown). Thus, it seems probable
that the increased polymerase activity of PFV RT somehow
enhances the ability of the polymerase to cause the primer
strand to “jump” to other regions of the template, creating a
deletion. It is unclear how the sequence of the DNA being
copied interacts with PFV RT to favor such jumps, or why the
RT would pause or to detach from the template strand.
Deletions, on the whole, would be disadvantageous for a
retrovirus because virtually the entire genome is essential and it
is highly likely that crucial sequences would be lost if a
significant segment of the genome is deleted. However, two
separate groups have detected deletions within the long terminal
repeat (LTR) of PFVafter tissue culture passage, suggesting that
deletions do occur during PFV replication (De Celis-Kosmas et
al., 1997; Schmidt et al., 1997). Both groups suggested that the
deletions occurred by misalignment during reverse transcrip-
tion; both deletions were greater than 100 bp and arose in the U3
region of the PFV LTR (De Celis-Kosmas et al., 1997; Schmidt
et al., 1997). However, it is not known at what frequency these
deletions arise in vivo, where infection is persistent and
primarily latent (Murray et al., 2006). If the deletion mechanism
involves primer “jumping”, it would also explain the high level
of duplicated sequences (16/208 mutations). However, some of
these insertions could arise from template switching. Again, the
start points for these mutations appear to be random
(Supplementary material) and sequence homologies do not
appear to be involved in generating most of the duplications.
We have described a region in PFV RT that may correspond
to the basic loop found in both E. coli RNase H and near the
RNase H domain of MLV RT (Boyer et al., 2004a,b). The basic
loop is probably involved in binding the template-primer, and
may play a role in the greater processivity exhibited by PFV RT.
It could also contribute to the template jumping we detected. If
the interactions of the RNase H domain (and the basic loop) and
template-primer are strong when the PFV RT thumb, palm, and
fingers subdomains lose contact with the template-primer, the
RNase H region could remain bound to the substrate. The
polymerase domain of PFV RT could then make contact
elsewhere on the template while the template-primer is held by
RNase H, and the original primer would be extended on the new
region of the template. In HIV-1 RT, if the polymerase domain
loses contact with the original template-primer, the RNase H
domain (which has no basic loop) may not be able to maintain
contact and the HIV-1 RT may disassociate from the template-
primer completely. However, HIV-1 RT does make additional
contacts in its connection subdomain with the template-primer
and it is not clear whether the C-terminal region of HIV-1 RT
makes contacts with the template-primer that are weaker than
the corresponding contacts made by PFV RT. The RNase H
domains of the two RTs are different; for example, the RNase H
of HIV-1 RT cleaves an RNA substrate at −17 and −8 from the
3′ end of the primer strand, while the RNase H of PFV RT
cleaves at −17, −12, and −8 (Boyer et al., 2004a,b).
A previously described mutation at the PFV RT active site
(YMDD) decreased polymerase activity of the PFV RT in vitro
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this mutated RT do not replicate efficiently and revert to the
wild-type YVDD sequence (Rinke et al., 2002), suggesting that
the virus requires a high level of polymerase activity to replicate
efficiently (Rinke et al., 2002). If the in vitro assays replicate the
in vivo properties of PFV RT, then the high level of deletions,
repeats, and frameshifts do not seem to interfere with viral
replication. It is possible that when PFV RT copies the RNA
genome during the normal viral life cycle, that it makes fewer
errors than it does in vitro. This could be due to the presence of
viral and/or cellular proteins that could help the enzyme make a
more faithful DNA copy. It is interesting to speculate on
whether the level of fidelity of these two RTs relates to their
pathogenicity. Unlike HIV-1, PFV does not appear to cause
disease in humans. The replicative cycles of the two retroviruses
are quite different, which could play a role in determining what
level of mutations arise and what kind of mutations are tolerated
by the virus. In untreated patients, HIV-1 replicates at a
relatively high rate; this high rate of replication helps HIV-1
generate quasi-species during infection and avoid immune
constraints imposed by the host (e.g., Brown, 1997; Ganeshan
et al., 1997; Van Laethem et al., 2005, and references therein).
Because the variation arises in response to immune pressure,
many of the mutations occur within the env coding region. In
contrast, the foamy viruses appear to be relatively genetically
stable in vivo. SFV isolated from a large number of African
green monkeys and from a seropositive animal caretaker
infected by virus from these animals show relatively little
variation in the env genes. The SFV env genes fall into four
groups, but were all at least 75% identical at the nucleic acid
level (with no hypervariable region) and within each group,
there was N95% identity. Virus was isolated from one animal
seven times over a span of 15 years, and the sequences were
N99.5% identical. These studies suggest that for this virus, like
HTLV-1, genetic variation is not a factor in the maintenance of
persistent infections (Schweizer et al., 1997, 1999). One
explanation that has been suggested for this lack of genetic
variability compared to other retroviruses is that the FV RT has
a higher fidelity than other retroviral RTs. However, from the
data presented here, it is clear that PFV RT has a fidelity similar
to HIV-1 RT for base substitutions, and generates more
insertions and deletions. Like HIV-1, PFV must evade the
host's immune system. However, unlike HIV-1, there is little
variation in the sequences of the foamy virus genome. Also,
unlike HIV-1, there is little detectable FV viral replication in the
host (Delelis et al., 2004; Falcone et al., 2003). Foamy
proviruses can be found in many different tissues, but
replication has been detected only in oral tissues (Murray et
al., 2006). PFV is sensitive to the APOBEC family of antiviral
cytidine deaminases, and it has been proposed that the low level
of replication, and the fact that the cells the virus replicates in
have low levels of the APOBEC proteins, are the primary
mechanisms of persistence of FV in the host (Delebecque et al.,
2006). These mechanisms allow PFV to persist in the host
without significant genetic variation. Our in vitro data supports
this model. PFV RT is at least as error prone as other retroviral
RTs.Materials and methods
Plasmids
Litmus 29 was obtained from New England BioLabs. The
plasmid contains an M13 origin of replication, which will allow
the generation of single-stranded phagemid DNA, and a
restriction enzyme recognition site polylinker, which includes
a recognition site for BamHI 5′ of the coding region for the
LacZα-complementing fragment. Litmus 29 was linearized
with HpaI, ligated to NotI linkers (New England BioLabs), and
recircularized to make Litmus 29 (Not). The new NotI
recognition sequence is located 3′ of the lacZα-coding region.
Litmus 29 (Not) was linearized with BamHI/NotI and ligated to
a 1.7-kb fragment containing the coding region from HIV-1 RT
and a short flanking sequence to yield the plasmid B/N RT
(His). The LacZα-coding region was completely removed from
this vector.
Formation of single-strand uracil-containing DNA
The protocol is similar to that described previously (Boyer
and Hughes, 2000) with a modification (described below). The
construct Litmus 29 (Not) was introduced into the Dut– Ung–
male E. coli strain CJ236 (New England BioLabs). The uracil
base can appear in DNA as a result of deamination of a cytosine
base, and is a potential mutating event. Therefore, the E. coli
Ung gene encodes a uracil–DNA glycosylase that will remove
the uracil base from the DNA, a first step in allowing other
DNA repair enzymes to restore the normal sequence. Dut is the
E. coli gene encoding a dUTPase, which prevents high levels of
dUTP from accumulating in the cell, since dUTP can be
incorporated into DNA in place of dTTP during DNA synthesis
by DNA polymerases. Dut– Ung– male E. coli strain will have
higher than normal levels of dUTP, which increases the
opportunities for deoxyuracil residues being inserted into the
plasmid DNA during replication; lack of the Ung gene means
that these uracil residues will not be removed from the DNA.
The DNA containing the deoxyuracil residues is designated U-
DNA. To generate single-stranded U-DNA Litmus 29 (Not), the
helper phage M13K07 (New England BioLabs) was used
according to the protocol suggested by New England BioLabs.
The proteins of the M13K07 helper phage will recognize the
M13 origin in the Litmus-29 (Not) and will replicate the
plasmid as single-stranded DNA and package it within M13
virions. Since the replication occurs in a Dut– Ung– male E. coli
strain, this single-stranded DNAwill contain uracil residues. To
generate the single-stranded U-DNA, 50 ml of Luria–Bertani
medium supplemented with uridine (0.25 μg/ml) was inocu-
lated with a colony of Litmus 29 (Not) in CJ236. The culture
was incubated at 37 °C with agitation until the solution was
slightly turbid. The helper phage M13K07 was added to a final
concentration of 108 PFU/ml. The culture was incubated at
37 °C with agitation for an additional 60 min. Kanamycin was
added to a final concentration of 70 μg/ml, and the culture was
incubated overnight at 37 °C. Bacteria were removed by
sedimentation twice at 8000 rpm for 10 min. One-fifth volume
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(NaCl–PEG) was added to the supernatant, and the solution was
incubated on ice for 2 h. The phage particles were isolated by
centrifugation at 8000 rpm for 10 min. The pellet was
resuspended in 1.6 ml of 10 mM Tris–Cl (pH 8.0)–1.0 mM
EDTA (TE) and divided into two tubes. The solution was
clarified by centrifugation in a microcentrifuge at full speed to
remove any remaining bacteria. MgCl2 was added to a final
concentration of 10 mM, and DNase was added to the solution
to remove contaminating bacterial and double-stranded phage
DNA released by bacterial lysis. Intact phage particles were
isolated by the addition of 200 μl of NaCl–PEG solution to each
tube and centrifugation in a microcentrifuge for 5 min at full
speed. The phage pellet was resuspended in 300 μl of TE and
extracted three times with phenol-chloroform. After the addition
of NaCl to a final concentration of 50 mM, the phage DNAwas
precipitated with 1 volume of isopropanol, then resuspended in
400 μl of H2O, and stored at −20 °C. The modification to the
previously described protocol is an additional purification step.
The QIAprep M13 isolation procedure removes residual
phenol-chloroform, PEG, and bacterial debris that may be
present with the DNA. 10.0 μg of single-stranded DNA was
mixed into 5 volumes of buffer MLB (provided by Qiagen). The
single-stranded DNA binds to the column, which was washed
according to the supplier's protocol. The single-stranded DNA
was eluted, the concentration determined by UV absorbance,
and the DNA stored at −20 °C.
Fidelity assay
The fidelity assay involves the copying of a DNA segment
that encodes the α-complementing peptide of E. coli β-
galactosidase. The fidelity primer (5′ CCC ATG GTG AAG
CTT GGA TCC ACG ATA TCC TGC AGG 3′; Life Tech-
nologies, Inc., Rockville, MD) matches the sequence surround-
ing the BamHI recognition site in the Litmus 29 polylinker. For
each fidelity assay, 2.5 μl from a 10.0-A260/ml stock of fidelity
primer was annealed to 1.0 μg of single-stranded U-DNA
(described above) by heating and slow cooling. Each sample
was adjusted to contain 25 mM Tris–Cl (pH 8.0), 75 mM KCl,
8.0 mM MgCl2, 2 mM dithiothreitol, 100 μg of bovine serum
albumin per ml, 10 mM CHAPS {3-[(3-cholamidopropyl)-
dimethylammonio]-1-propanesulfonate}, and 20 μM each
dATP, dCTP, dGTP, and dTTP. The fidelity primer was extended
in vitro by either the HIV-1 or PFV reverse transcriptase (RT), so
that the DNA segment encoding the α-complementing peptide
was copied. One microgram of either wild-type HIV-1 RTor the
PFV RTwas added, and the samples were incubated for 10 min
at 37 °C. The reactions were stopped by the addition of 1 volume
of phenol-chloroform, followed by isopropanol precipitation
and a 70% ethanol wash. The extended template primers were
digested with BamHI and NotI, and the resulting fragments
were fractionated on a 2% SeaPlaque (FMC) low-melting-point
agarose gel. If the RT copied the lacZα portion of the template
past the NotI recognition sequence, a band approximately
300 bp in size was visible in the gel. Primers that were not
extended past the NotI site were annealed to phage DNA thatwas linearized with BamHI, which migrated near the top of the
gel. The BamHI/NotI fragment encoding LacZα was isolated
from the gel and purified. As described above, Litmus 29 (Not)
contains a fully functional LacZα-coding region. Attempting to
remove this fragment and replace it with the BamHI/NotI
fragment generated by the fidelity assay could lead to a high
background of positive colonies that would not derive from
DNA synthesized by RT. Therefore, the construct B/N RT (His)
was used to clone the BamHI/NotI fragment. This vector does
not contain the LacZα-coding region. B/N RT (His) was
linearized with BamHI and NotI, and the vector band was
isolated from a 2% SeaPlaque low-melting-point agarose gel.
This isolated linear DNA segment was ligated to the BamHI/
NotI lacZα fragments described above. The ligation mixture
was electroporated into electrocompetent DH10B cells (Life
Technologies, Inc.) and plated on NZY (10.0 g of NZ amine,
5.0 g of NaCl, 5.0 g of yeast extract, and 2.0 g of MgSO4 per
liter)-ampicillin plates supplemented with 5-bromo-4-chloro-3-
indolyl-D-galactopyranoside (X-Gal; Life Technologies).
DH10B is a Dut+ Ung+ E. coli strain, which preferentially
degrades the template strand because it contains deoxyuracil as
described above. The primer strand copied by the RTs is retained
and gives rise to the recovered plasmid DNA. The dark blue,
light blue, and white colonies were then counted. DNA was
isolated from the light blue and white colonies and sequenced to
determine the nature of the mutations. Litmus-29(Not) contains
a multiple cloning site; therefore, the LacZα peptide contains
additional amino acids at the N terminus. Since only base
substitutions that create a termination codon and mutations
which insert or delete sequences would be detected in this
region, the target for mutagenesis was defined as starting at a
glycine codon (as shown in Figs. 1–3) and stopping at the first
termination codon. The entire target sequence thus defined is
174 nucleotides in length.
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